Email Not Verified

Action Required

Please go to your profile settings and make sure your email is verified before applying for account verification.

Please refer to the documentation here.

Confirm Account Verification

Final Step

Please make sure you have filled in all the required details.

We need these details to verify your account. Once you click Yes, we will send an account activation request to our team.

Please refer to the documentation here.

Incomplete Profile

Missing Information Required

Here are all required fields. Complete the remaining ones before applying:

Back to Top
Go Back
Journal Photo for Therapeutic Advances in Hematology
Peer reviewed only Open Access

Therapeutic Advances in Hematology (TAH)

Publisher : SAGE
Hematology Clinical Hematology Hematologic Malignancies
Claim Your Journal Get PRC Visit Website
e-ISSN 2040-6215
p-ISSN 2040-6207
Issue Frequency Continuously
Est. Year 2010
Mobile 4402073248500
Language English
APC YES
Email info@sagepub.co.uk

Journal Descriptions

Therapeutic Advances in Hematology is an international, peer-reviewed, fully Gold Open Access journal published by SAGE Publishing. Established in 2010, the journal focuses on the latest therapeutic developments, clinical research, and evidence-based advances in the diagnosis and treatment of hematological disorders. It serves as a valuable resource for hematologists, oncologists, transfusion medicine specialists, clinical researchers, pharmacists, and healthcare professionals involved in the management of blood diseases. The journal publishes original research articles, systematic reviews, narrative reviews, meta-analyses, clinical trials, case reports, editorials, and expert perspectives covering both malignant and non-malignant hematological conditions. Major topics include leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes, myeloproliferative neoplasms, anemia, hemophilia, thrombosis, coagulation disorders, stem cell transplantation, immunotherapy, targeted therapies, gene therapy, and precision medicine. The journal particularly emphasizes clinically relevant research that can improve patient care and therapeutic outcomes. All manuscripts undergo rigorous peer review to ensure scientific quality, originality, and clinical relevance. The journal is indexed in major databases including PubMed, PubMed Central, Scopus, and Science Citation Index Expanded (SCIE), providing broad international visibility. As a fully open-access journal, all accepted articles are freely accessible worldwide immediately upon publication, promoting rapid dissemination of advances in hematology.

Therapeutic Advances in Hematology (TAH) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Hematology, Clinical Hematology, Hematologic Malignancies, Leukemia, Lymphoma, Multiple Myeloma, Coagulation Disorders, Transfusion Medicine, Stem Cell Transplantation, Targeted and Precision Therapies, leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes, myeloproliferative neoplasms, anemia, hemophilia, thrombosis, coagulation disorders, stem cell transplantation, immunotherapy, targeted therapies, gene therapy, precision medicine , Online or Print , Continuously Journal

  • UGC Approved, ISSN Approved: P-ISSN P-ISSN: 2040-6207, E-ISSN: 2040-6215, Established: 2010,
  • Does Not Provide Crossref DOI

  • Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE